CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- PX14A6G Other Notice of Exempt Solicitation Submitted by Non-management
- DEFA14A Proxy Proxy Materials
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- SUPPL Other SUPPL
- SUPPL Other SUPPL
- SUPPL Other SUPPL
- EFFECT Other Notice of Effectiveness
- F-10/A Other F-10/A
- S-8 Other Securities Offered to Employees in Benefit Plans
- F-X Other F-X
- F-10 Other F-10
- 40-F Report 40-F
- SUPPL Other SUPPL
- SUPPL Other SUPPL
Page 2 of 4 · 74 filings